# TSS, Inc.: financial statements, quarterly

TSSI · Nasdaq · CIK 1320760 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tssi.md) · [Financials](/companies/tssi/financials.md) · [Filings](/companies/tssi/filings.md) · [Insiders](/companies/tssi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tssi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.9](/filings/0001437749-24-035318.md) | [24.4 d](/filings/0001654954-26-002342.md) | [15.9](/filings/0001654954-25-005742.md) | [12.2](/filings/0001654954-25-009327.md) | [70.1](/filings/0001654954-25-012989.md) | [50.0 d](/filings/0001654954-26-002342.md) | [99.0](/filings/0001654954-26-004534.md) | [44.0](/filings/0001654954-26-007668.md) | [41.9](/filings/0001654954-25-012989.md) | [60.9 d](/filings/0001654954-26-002342.md) | [55.3](/filings/0001654954-26-004534.md) | [34.9](/filings/0001654954-26-007668.md) |
| Cost of revenue | $m | [6.1](/filings/0001437749-24-035318.md) | [21.1 d](/filings/0001654954-26-002342.md) | [13.2](/filings/0001654954-25-005742.md) | [7.6](/filings/0001654954-25-009327.md) | [62.2](/filings/0001654954-25-012989.md) | [42.8 d](/filings/0001654954-26-002342.md) | [89.7](/filings/0001654954-26-004534.md) | [36.8](/filings/0001654954-26-007668.md) | [37.2](/filings/0001654954-25-012989.md) | [49.6 d](/filings/0001654954-26-002342.md) | [46.5](/filings/0001654954-26-004534.md) | [27.1](/filings/0001654954-26-007668.md) |
| Gross profit | $m | [2.8](/filings/0001437749-24-035318.md) | [3.3 d](/filings/0001654954-26-002342.md) | [2.7](/filings/0001654954-25-005742.md) | [4.5](/filings/0001654954-25-009327.md) | [7.9](/filings/0001654954-25-012989.md) | [7.2 d](/filings/0001654954-26-002342.md) | [9.2](/filings/0001654954-26-004534.md) | [7.2](/filings/0001654954-26-007668.md) | [4.6](/filings/0001654954-25-012989.md) | [11.3 d](/filings/0001654954-26-002342.md) | [8.8](/filings/0001654954-26-004534.md) | [8.0](/filings/0001654954-26-007668.md) |
| Selling, general and administrative | $m | [2.0](/filings/0001437749-24-035318.md) | [2.5 d](/filings/0001654954-26-002342.md) | [2.4](/filings/0001654954-25-005742.md) | [2.7](/filings/0001654954-25-009327.md) | [3.9](/filings/0001654954-25-012989.md) | [4.2 d](/filings/0001654954-26-002342.md) | [4.9](/filings/0001654954-26-004534.md) | [4.7](/filings/0001654954-26-007668.md) | [5.2](/filings/0001654954-25-012989.md) | [5.8 d](/filings/0001654954-26-002342.md) | [5.5](/filings/0001654954-26-004534.md) | [5.6](/filings/0001654954-26-007668.md) |
| Operating income | $m | [0.7](/filings/0001437749-24-035318.md) | [(1.2) d](/filings/0001654954-26-002342.md) | [0.3](/filings/0001654954-25-005742.md) | [1.7](/filings/0001654954-25-009327.md) | [3.8](/filings/0001654954-25-012989.md) | [0.0 d](/filings/0001654954-26-002342.md) | [2.6](/filings/0001654954-26-004534.md) | [1.4](/filings/0001654954-26-007668.md) | [(0.9)](/filings/0001654954-25-012989.md) | [0.9 d](/filings/0001654954-26-002342.md) | [2.3](/filings/0001654954-26-004534.md) | [1.6](/filings/0001654954-26-007668.md) |
| Interest expense | $m | [0.5](/filings/0001437749-24-035318.md) | [0.7 d](/filings/0001654954-25-004295.md) | [0.3](/filings/0001654954-25-005742.md) | [0.4](/filings/0001654954-25-009327.md) | [1.3](/filings/0001654954-25-012989.md) | [0.7 d](/filings/0001654954-25-004295.md) | [1.5](/filings/0001654954-25-005742.md) | [0.9](/filings/0001654954-25-009327.md) | [1.0](/filings/0001654954-25-012989.md) | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001437749-24-035318.md) | [0.0 d](/filings/0001654954-26-002342.md) | [0.0](/filings/0001654954-25-005742.md) | [0.0](/filings/0001654954-25-009327.md) | [0.0](/filings/0001654954-25-012989.md) | [0.1 d](/filings/0001654954-26-002342.md) | [0.0](/filings/0001654954-26-004534.md) | [0.1](/filings/0001654954-26-007668.md) | [0.1](/filings/0001654954-25-012989.md) | [(7.8) d](/filings/0001654954-26-002342.md) | [0.4](/filings/0001654954-26-004534.md) | [0.4](/filings/0001654954-26-007668.md) |
| Net income | $m | [0.2](/filings/0001437749-24-035318.md) | [0.3 d](/filings/0001654954-26-002342.md) | [0.0](/filings/0001654954-25-012989.md) | [1.4](/filings/0001654954-25-012989.md) | [2.6](/filings/0001654954-25-012989.md) | [1.9 d](/filings/0001654954-26-002342.md) | [3.0](/filings/0001654954-26-007668.md) | [1.5](/filings/0001654954-26-007668.md) | [(1.5)](/filings/0001654954-25-012989.md) | [12.2 d](/filings/0001654954-26-002342.md) | [2.3](/filings/0001654954-26-007668.md) | [1.4](/filings/0001654954-26-007668.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001437749-24-035318.md) | not reported | [0.00](/filings/0001654954-25-005742.md) | [0.06](/filings/0001654954-25-009327.md) | [0.10](/filings/0001654954-25-012989.md) | not reported | [0.12](/filings/0001654954-26-004534.md) | [0.06](/filings/0001654954-26-007668.md) | [(0.06)](/filings/0001654954-25-012989.md) | not reported | [0.08](/filings/0001654954-26-004534.md) | [0.05](/filings/0001654954-26-007668.md) |
| Basic EPS | $ per share | [0.01](/filings/0001437749-24-035318.md) | not reported | [0.00](/filings/0001654954-25-005742.md) | [0.06](/filings/0001654954-25-009327.md) | [0.12](/filings/0001654954-25-012989.md) | not reported | [0.13](/filings/0001654954-26-004534.md) | [0.06](/filings/0001654954-26-007668.md) | [(0.06)](/filings/0001654954-25-012989.md) | not reported | [0.08](/filings/0001654954-26-004534.md) | [0.05](/filings/0001654954-26-007668.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [28.7](/filings/0001437749-23-031647.md) | [11.8](/filings/0001437749-24-035318.md) | [14.4](/filings/0001437749-24-016663.md) | [8.3](/filings/0001437749-24-026834.md) | [46.4](/filings/0001437749-24-035318.md) | [23.2](/filings/0001654954-26-007589.md) | [27.3](/filings/0001654954-26-004534.md) | not reported | [70.7](/filings/0001654954-25-012989.md) | [85.5](/filings/0001654954-26-007668.md) | [66.0](/filings/0001654954-26-004534.md) | [67.7](/filings/0001654954-26-007668.md) |
| Current assets | $m | [38.1](/filings/0001437749-23-031647.md) | [19.3](/filings/0001654954-25-004295.md) | [20.5](/filings/0001437749-24-016663.md) | [21.2](/filings/0001437749-24-026834.md) | [59.9](/filings/0001437749-24-035318.md) | [58.2](/filings/0001654954-26-002342.md) | [61.1](/filings/0001654954-25-005742.md) | [70.9](/filings/0001654954-25-009327.md) | [100](/filings/0001654954-25-012989.md) | [119](/filings/0001654954-26-007668.md) | [88.7](/filings/0001654954-26-004534.md) | [103](/filings/0001654954-26-007668.md) |
| Total assets | $m | [44.6](/filings/0001437749-23-031647.md) | [25.6](/filings/0001654954-25-004295.md) | [26.8](/filings/0001437749-24-016663.md) | [28.9](/filings/0001437749-24-026834.md) | [67.3](/filings/0001437749-24-035318.md) | [96.6](/filings/0001654954-26-002342.md) | [114](/filings/0001654954-25-005742.md) | [139](/filings/0001654954-25-009327.md) | [165](/filings/0001654954-25-012989.md) | [185](/filings/0001654954-26-007668.md) | [154](/filings/0001654954-26-004534.md) | [175](/filings/0001654954-26-007668.md) |
| Current liabilities | $m | [37.7](/filings/0001437749-23-031647.md) | [18.4](/filings/0001654954-25-004295.md) | [19.6](/filings/0001437749-24-016663.md) | [19.4](/filings/0001437749-24-026834.md) | [55.6](/filings/0001437749-24-035318.md) | [56.9](/filings/0001654954-26-002342.md) | [72.2](/filings/0001654954-25-005742.md) | [87.2](/filings/0001654954-25-009327.md) | [66.0](/filings/0001654954-25-012989.md) | [72.6](/filings/0001654954-26-007668.md) | [40.6](/filings/0001654954-26-004534.md) | [62.2](/filings/0001654954-26-007668.md) |
| Total liabilities | $m | [41.5](/filings/0001437749-23-031647.md) | [22.1](/filings/0001654954-25-004295.md) | [23.1](/filings/0001437749-24-016663.md) | [23.8](/filings/0001437749-24-026834.md) | [59.6](/filings/0001437749-24-035318.md) | [89.4](/filings/0001654954-26-002342.md) | [104](/filings/0001654954-25-005742.md) | [130](/filings/0001654954-25-009327.md) | [102](/filings/0001654954-25-012989.md) | [108](/filings/0001654954-26-007668.md) | [74.9](/filings/0001654954-26-004534.md) | [95.0](/filings/0001654954-26-007668.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001654954-25-004295.md) | not reported | not reported | not reported | [8.2](/filings/0001654954-26-002342.md) | [8.2](/filings/0001654954-25-005742.md) | [19.5](/filings/0001654954-25-009327.md) | [19.0](/filings/0001654954-25-012989.md) | [14.0](/filings/0001654954-26-007668.md) | [13.0](/filings/0001654954-26-004534.md) | [11.9](/filings/0001654954-26-007668.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001654954-26-002342.md) | not reported | not reported | [4.9](/filings/0001654954-25-012989.md) | [4.0](/filings/0001654954-26-007668.md) | [4.1](/filings/0001654954-26-004534.md) | [4.2](/filings/0001654954-26-007668.md) |
| Shareholders' equity | $m | [3.1](/filings/0001437749-24-035318.md) | [3.5](/filings/0001654954-26-002342.md) | [3.7](/filings/0001654954-25-012989.md) | [5.2](/filings/0001654954-25-012989.md) | [7.7](/filings/0001654954-25-012989.md) | [7.1](/filings/0001654954-26-007668.md) | [9.4](/filings/0001654954-26-007668.md) | [9.5](/filings/0001654954-26-007668.md) | [63.4](/filings/0001654954-25-012989.md) | [76.6](/filings/0001654954-26-007668.md) | [78.7](/filings/0001654954-26-007668.md) | [80.3](/filings/0001654954-26-007668.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.6 d](/filings/0001437749-24-035318.md) | [(16.8) d](/filings/0001654954-26-002342.md) | [2.6](/filings/0001654954-25-005742.md) | [(4.3) d](/filings/0001654954-25-009327.md) | [38.6 d](/filings/0001654954-25-012989.md) | [(21.6) d](/filings/0001654954-26-002342.md) | [20.6](/filings/0001654954-26-004534.md) | [16.3 d](/filings/0001654954-26-007668.md) | [(18.4) d](/filings/0001654954-25-012989.md) | [16.3 d](/filings/0001654954-26-002342.md) | [(14.9)](/filings/0001654954-26-004534.md) | [7.6 d](/filings/0001654954-26-007668.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-24-035318.md) | [0.0 d](/filings/0001654954-26-002342.md) | [0.0](/filings/0001654954-25-005742.md) | [1.7 d](/filings/0001654954-25-009327.md) | [0.0 d](/filings/0001654954-25-012989.md) | [6.7 d](/filings/0001654954-26-002342.md) | [14.9](/filings/0001654954-26-004534.md) | [10.9 d](/filings/0001654954-26-007668.md) | [6.4 d](/filings/0001654954-25-012989.md) | [0.5 d](/filings/0001654954-26-002342.md) | [0.5](/filings/0001654954-26-004534.md) | [4.1 d](/filings/0001654954-26-007668.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-035318.md) | [0.0 d](/filings/0001654954-26-002342.md) | [0.1](/filings/0001654954-25-005742.md) | [0.1 d](/filings/0001654954-25-009327.md) | [0.6 d](/filings/0001654954-25-012989.md) | [3.7 d](/filings/0001654954-26-002342.md) | [1.7](/filings/0001654954-26-004534.md) | [2.3 d](/filings/0001654954-26-007668.md) | [1.0 d](/filings/0001654954-25-012989.md) | [0.0 d](/filings/0001654954-26-002342.md) | [1.4](/filings/0001654954-26-004534.md) | [0.9 d](/filings/0001654954-26-007668.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.5](/filings/0001437749-23-031647.md) | [21.5](/filings/0001437749-24-016663.md) | [23.8](/filings/0001437749-24-026834.md) | [21.9](/filings/0001437749-24-035318.md) | [22.4](/filings/0001654954-25-005742.md) | [24.7](/filings/0001654954-25-009327.md) | [26.3](/filings/0001654954-25-012989.md) | [25.9](/filings/0001654954-26-004534.md) | [25.8](/filings/0001654954-26-007668.md) | [25.5](/filings/0001654954-25-012989.md) | [29.4](/filings/0001654954-26-004534.md) | [29.6](/filings/0001654954-26-007668.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,219,070 at 2026-08-07, from the cover of the [10-Q/A filed 2026-08-14](/filings/0001654954-26-007668.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.